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a  b  s  t  r  a  c  t
Hair  cortisol  concentrations  (HCC)  have  been  suggested  to  reﬂect  long-term  integrated  cortisol  levels,
but  most  evidence  of  associations  with co-variates  is from  small  samples  of  healthy  volunteers.
The objective  of  this  study  was  to describe  the collection  of hair  samples  in  a  large  cohort  study  and
report  associations  of  demographic  and health  measures  with  HCC.  We  examined  HCC  measured  from
the  3  cm hair  segment  near the  scalp  in 3507  participants  (aged  59–83  y) from  The  Whitehall  II occu-
pational  cohort  study  of  British  civil  servants.  Hair  samples  were  analysed  using  a  column  switching
LC–APCI–MS/MS  assay.  Findings  from  mutually  adjusted  linear  regression  analyses  revealed  lower  HCC
in participants  who  reported  use  of  hair  dye  [%  difference  (95%CI);  −12.5 (−22.0, −1.9), p value  =  0.022]
and evidence  suggestive  of differences  by  length  of  sample  storage  and  seasonal  variation.  With regard
to  demographic  variables,  HCC  was  lower  in  women  compared  to men  [−17.0  (−24.8,  −8.4),  p  value
<0.001]  and  higher  in Black  compared  to other  ethnic  groups.  Prevalent  diabetes,  use  of systemic  corti-
costeroids  and  cardiovascular  medication  were  independently  associated  with  higher HCC.  With  regard
to health,  depressive  symptoms  were  associated  with  higher  HCC  [20.0  (8.1,  33.3),  p  value  = 0.001]  fol-
lowing  adjustment  for  physical  disease  and  medication.  We  conclude  that  hair  steroid  analysis  presents
signiﬁcant  opportunities  for  assessing  cortisol  in  large  scale  cohorts.  Demographic  factors,  sample  stor-
age, season  of  collection  and  hair  characteristics  should  be considered  in  future analyses.  Health  status,
both  mental  and  physical,  is linked  to HCC.
© 2016  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license. Introduction
Understanding the role of stress in health continues to be
 major aim in epidemiological research. Activation of the
ypothalamic-pituitary-adrenal (HPA) axis is a primary response
o a stressful stimulus and cortisol, the end product of the HPA
xis, which may  mark exposure to chronic stress, is proposed as a
ediator between adverse social conditions and physical health.
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Observational surveys frequently collect cortisol from their par-
ticipants to allow these pathways between stress and health to be
examined. Traditionally, the assessment of cortisol in observational
surveys has been through measurements in blood, saliva or urine.
However, high state reactivity and the pulsatile secretion of corti-
sol (Hellhammer et al., 2007; Lightman et al., 2008; Young et al.,
2004) mean single measurements reﬂect short-term levels, rang-
ing from minutes (plasma or saliva) to hours (urine), and provide
limited information about long-term cortisol secretion. Repeated
ambulatory measurements which capture longer-term levels, are
time-consuming, expensive and may include high proportions of
missing data due to participant non-compliance (Broderick et al.,
2004). In addition, these methods are often invasive and require
a clinic environment to aid collection or they require high lev-
els of commitment from the participants, which becomes harder
to request in certain groups e.g. studies of ageing. Thus, blood,
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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aliva and urine measures, while well-suited for capturing dynamic
spects of endocrine activity, (e.g., acute stress reactivity or diurnal
hythmicity), are less useful as markers of the long-term secretory
atterns. However, long-term cortisol levels may be important in
he aetiology of chronic disease, since the cumulative burden of
requent or enduring HPA axis activation may  be associated with a
ange of maladaptive effects on the organism.
Hair cortisol concentration (HCC) can provide an alternative
ssessment method, capturing information about cortisol levels
ver the course of several months. The collection of hair samples
s non-invasive and can be performed by non-health care workers
t any time of the day. Hair samples can also be stored at room
emperature and be sent by mail. Although forensic science and
oxicology have an established history of analysing hair for exoge-
ous substances, recent reports that endogenous steroids can also
e detected in hair have expanded research using human hair sam-
les (Meyer and Novak, 2012; Russell et al., 2012; Stalder and
irschbaum, 2012). Direct and in-direct validation studies have
onﬁrmed the capacity of these measures to provide an index of
ntegrated long-term cortisol secretion (Meyer and Novak, 2012;
ussell et al., 2012; Stalder and Kirschbaum, 2012) despite lack of
nderstanding of the precise means by which cortisol is incorpo-
ated into the hair shaft (Sharpley et al., 2012). High intra-individual
tability in HCC supports the use of this method in epidemiologi-
al research to assess long- term cortisol secretion (Stalder et al.,
012b).
Several issues potentially affect HCC measurements. First, small
cale studies have documented differences in HCC by a range of
haracteristics such as sex, age and ethnicity implying that with-
ut controlling for these and other confounding factors, biased
esults could be obtained (Russell et al., 2012; Sharpley et al.,
012; Staufenbiel et al., 2015; Wosu et al., 2013). Second, differ-
nces in HCC by physical and mental health have been observed,
ith elevated HCC in patients with chronic conditions such as dia-
etes (Feller et al., 2014; Henley et al., 2013; Manenschijn et al.,
013) and myocardial infarction (Pereg et al., 2011) as well as
ental health problems (Staufenbiel et al., 2013). These ﬁndings
uggest that when measuring HCC it may  be important to take into
ccount health status, although these studies were often composed
f small samples of patients or based on self-reported diagnoses and
herefore the exact effect on HCC remains unclear. Third, human
air is exposed to exogenous factors, including hair maintenance
roducts, such as hair dye, shampoo and chemical treatments. Iden-
ifying whether these factors are potential sources of measurement
rror is crucial (Dettenborn et al., 2012b; Feller et al., 2014; Wosu
t al., 2015). Although certain characteristics, such as dyeing and
ther chemical treatment of hair have been found to be associated
ith reduced HCC (Manenschijn et al., 2011; Stalder et al., 2013),
amples have not always been large enough to examine the full
ange of hair maintenance procedures.
To date, HCC has been assessed in some larger samples up to
 = 1258 (Braig et al., 2015; Feller et al., 2014; Stalder et al., 2013;
taufenbiel et al., 2015) but the majority of them may  lack repre-
entiveness, being drawn from volunteers. To address limitations
f sample size and generalisability we assessed HCC in a large well-
haracterised longitudinal cohort study to examine the feasibility of
his measure for future observational research. Our objectives were
o describe the procedure of collecting and validating hair samples
or HCC analysis and to examine the association between HCC and a
ange of factors. We  examined these data in relation to hair charac-
eristics and demographical characteristics. We  also explored the
nﬂuence of sample storage and seasonal effects, the impact of
hich are not well known. Furthermore, we wished to examine
he association between clinically screened physical health events
nd mental health status with HCC.rinology 73 (2016) 148–156 149
2. Methods
2.1. Study population
The Whitehall II study is an occupational cohort origi-
nally recruited from London based Civil Service departments in
1985–1988 (phase 1). The initial sample consisted of 10,308 par-
ticipants who undertook a clinic screening and completed a postal
questionnaire. Follow up screening examinations were conducted
in 1991–1993 (phase 3) and 1997–1999 (phase 5), 2003–2004
(phase 7), 2007–2009 (phase 9) and 2012–2013 (phase 11). Postal
questionnaires were sent to participants in 1989 (phase 2), 1995
(phase 4), 2001 (phase 6) and 2006 (phase 8). Hair cortisol data
were collected for the ﬁrst time in 2012–2013 (phase 11). Further
details of the Whitehall II Study can be found elsewhere (Marmot
and Brunner, 2005). Ethical approval for the Whitehall II study was
obtained from the University College London Medical School com-
mittee on the ethics of human research.
2.2. Hair sample collection
A total of 6,308 participants were included in phase 11, of whom
5,660 undertook a clinical screening. A sample of hair was taken
from 4,460 participants, excluding those who  had insufﬁcient hair
(N = 997), who had a severe head tremor (N = 31) or who didn’t con-
sent (N = 172). Women  were more likely to provide a sample than
men  (78.6% vs. 67.4%). Hair strands taken from the head by a nurse
were cut carefully with scissors as close as possible to the scalp. Hair
was collected from the vertex posterior region of the head, since it
has been found that this area of the scalp has the greatest growth
cycle synchrony and exhibits the lowest intra-individual variability
in HCC (Sauve et al., 2007). Steroid concentrations were determined
from the 3 cm segment of hair closest to the scalp. This represents
hair growth over the three month period prior to sampling based
on an average hair growth of 1 cm/month (Wennig, 2000).
2.3. Sample preparation
The samples were analysed between 23rd June and 20th August
in 2014 using a column switching LC–APCI–MS/MS assay, which
has been found to be a sensitive, reliable method for quantifying
steroids in human hair (Gao et al., 2013). The samples were washed
and steroids extracted following the protocol described previously
(Gao et al., 2013; Stalder et al., 2012b) with minor changes to
allow analysis by liquid chromatography-tandem mass spectrome-
try (LC–MS/MS). The intra and inter-assay coefﬁcients of variation
(CVs) for cortisol analysis by this method have been reported to
range between 3.7% and 8.8%. 11 samples were not analysed due
to insufﬁcient sample or technical error. A total of 4449 samples
were analysed for HCC but samples that weighed less than 7.5 mg
(N = 404) were excluded from the analyses for this study as were
those with samples shorter than 3 cm (N = 61). Following sensitiv-
ity analysis, samples shorter than 3 cm (N = 193) but with sufﬁcient
weight were included, since shorter length alone was  not associ-
ated with differences in HCC. Samples in which the scalp end of
the hair was not obvious were also excluded (N = 7). This left a
total of 3,977 respondents, of whom 3,966 had also completed the
accompanying hair questionnaire.
2.4. Assessment of covariates
Information about hair-related characteristics was  collected via
a questionnaire administered when the hair sample was collected.
Participants were asked whether they dyed or treated (perm or
chemical treatment) their hair. They were also asked about the
number of times per week they washed their hair with shampoo.
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Table 1
Characteristics of study participants (N = 3675).
Characteristic N % Median HCC
Sex:
Male 2513 68.4 3.1
Female 1162 31.6 2.4
Age  groups:
59–64 932 25.4 2.9
65–74 1899 51.7 2.8
75–85 844 23.0 2.8
Ethnicity:
White 3460 94.2 2.9
South Asian 151 4.1 2.5
Black 36 1.0 5.3
Other 28 0.8 4.0
Grade:
Administrative 1811 49.3 3.0
Prof/exec 1529 41.6 2.8
Clerical/support 335 9.1 2.4
Original hair colour:
Grey/white 2876 78.3 2.9
Blonde 96 2.6 2.4
Red  32 0.9 2.9
Brown 473 12.9 2.8
Black 198 5.4 3.1
Hair dyed:
Yes 608 16.5 2.3
No  3067 83.5 3.0
Hair Treated:
Yes 149 4.1 2.6
No  3526 96.0 2.9
Hair washing freq.:
≤Once a week 1119 30.5 2.9
2–4  times per week 1716 46.7 2.8
>4  times per week 840 22.9 2.9
Season collected:
Winter 454 12.4 3.5
Winter-spring 561 15.3 2.6
Spring 320 8.7 2.2
Spring-summer 690 18.8 2.6
Summer 337 9.2 2.8
Summer-autumn 507 13.8 2.9
Autumn 332 9.0 3.1
Autumn-winter 474 12.9 3.2
Storage (months):
18 months or less 570 15.5 3.1
19–24 months 1557 42.4 3.2
>24  months 1548 42.1 2.5
Steroids medication:
No 3341 90.9 2.9
Yes  (local) 264 7.2 2.9
Yes  (systemic) 70 1.9 1.6
CVD drugs:
Yes 2174 59.2 2.9
No  1501 40.8 2.8
Diabetes:
No  3166 85.7 2.8
Yes  527 14.3 3.2
CHD:
No  2664 72.5 2.8
Yes  1011 27.5 3.1
Stroke:
No  3552 96.7 2.9
Yes  123 3.4 3.2
CES-D:
No  3239 88.1 2.8
Yes  436 11.9 3.1
BMI:
Underweight (<18.5) 46 1.25 2.4
Healthy weight (18.5–24.9) 1368 37.2 2.650 J.G. Abell et al. / Psychoneuro
his was recoded as: once a week or less, 2–4 times per week and
aily or 5–6 times per week. Interviewers’ assessed the colour of
he hair sample taken, although participants were also asked about
heir natural hair colour, if they had used hair dye. Seven categories
f hair colour were speciﬁed on the questionnaire (1: grey/white,
: blond, 3: red, 4: brown, 5: black, 6: don’t know, 7: other). These
ere recoded into ﬁve categories: (1) grey/white, (2) blonde (3)
ed, (4) brown, (5) black. If ‘don’t know’ was speciﬁed then this was
ecoded into missing. If ‘other’ was chosen and another hair colour
as speciﬁed in the open question provided, these were recoded.
Information on age, sex, last-known civil service employment
rade and ethnicity was obtained from the general questionnaire
t phase 11. Civil service employment grade was  deﬁned using
hree tiers: (1) administrative, (2) professional or executive and
3) clerical or support. Ethnicity was self-deﬁned as White, South
sian, Black or Other. Participants provided details of current med-
cations use (generic name, brand name, or both); these were
ubsequently coded using the British National Formulary. This
tudy used information about participants who used steroid med-
cation (local and systemic) and cardiovascular medication in the
ast 14 days. Date of hair collection was used to calculate variables
elated to length of sample storage and season of collection: win-
er (Dec, Jan, Feb), spring (Mar, Apr, May), summer (Jun.–Aug.)
nd autumn (Sep.–Nov.). An eight category variable was created
o take account of hair growth which during the three month sam-
le overlapped two seasons: (1: winter, 2: winter-spring, 3: spring,
: spring-summer, 5: summer, 6: summer-autumn, 7: autumn, 8:
utumn-winter). Mental health status was assessed using The Cen-
er for Epidemiologic Studies–Depression scale (CES–D), a 20 item
cale that measures symptoms of depression in the general pub-
ic, a score of 16+ has previously been used to classify depression
Radloff, 1977). Height and weight were measured using standard-
sed protocols during the medical examination and BMI  (kg/m2)
as calculated. Participants were asked about doctor diagnosis of
iabetes at each phase. Diabetes medication was extracted, again
sing British National Formulary codes (BNF). Venous blood was
aken at study phases 3, 5, 7, 9 and 11 to assess biomarkers, such
s fasting glucose and HbA1c (plasma cortisol was not measured).
revalent diabetes at phase 11 was deﬁned either by fasting glucose
fasting ≥7) (WHO, 2006) or HbA1c (≥6.5%) (WHO, 2011) or self-
eported diabetes; doctor diagnosis, use of insulin or oral glucose
owering drugs. Prevalent CHD was assessed from medical records
985–2009, supplemented by reports of doctor diagnosis at phase
1 and self-reports of a heart attack, angina pectoris or other heart
rouble since 2008. Stroke, likewise was assessed using medical
ecords up to phase 9 or doctor diagnosis/self-report of a stroke
ince 2008.
.5. Statistical analysis
HCC values were positively skewed and therefore log trans-
ormed to establish a normal distribution. Eighty-ﬁve outliers ±3SD
rom the mean were excluded from the analyses. The associa-
ion between each exposure variable (independent variable) and
CC was assessed initially using linear regression and subse-
uently using multiple regression with adjustment for potential
onfounding variables. Regression analyses were ﬁrst conducted on
emographics and hair related variables, followed by medication
nd health status. Percentage differences in mean HCC between the
evels of each exposure variable were calculated from the regres-
ion coefﬁcients for each exposure variable using the formula:
ercentage difference = (exp(coefﬁcient) − 1.0) × 100.Overweight (25–29.9) 1532 41.7 3.0
Obese (>30) 729 19.8 3.33. Results
Table 1 provides characteristics of the participants included in
the ﬁnal sample. This analysis was  based on 3675 participants who
J.G. Abell et al. / Psychoneuroendocrinology 73 (2016) 148–156 151
Table  2
Comparison of those included and excluded from the study samplea.
In study sample
(N = 3675)
Not in study sample
(N = 2633)
P value
Mean (SD) or % Mean (SD) or %
Sex (% men) 68.4 74.0 < 0.001
Age  (yr) 69.8 (5.8) 69.9 (6.0) 0.301
Ethnicity (% white) 94.2 90.5 <0.001
Employment grade (% lowest) 9.1 10.7 0.045
HCCb 3.5 (3.7) 6.3 (12.7) <0.001
Original hair colour (%grey/white) 78.3 79.8 0.100
Hair  dyed (% dyed) 16.5 20.8 0.004
Hair  treated (% treated) 4.1 4.7 0.408
Hair  washing freq. (once a week) 30.5 31.5 0.367
Season collected (% spring) 8.7 8.5 <0.001
Storage (% ≤18 months) 15.5 17.8 0.002
Steroid medication (% No) 90.9 91.4 0.544
CVD  drugs 40.8 37.7 0.011
BMI%  obese 19.8 19.0 0.179
Diabetes 85.7 83.8 0.035
CHD  72.5 74.0 0.187
Stroke 96.7 96.1 0.266
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a Among those eligible participants at phase 11 (N = 6308).
b Geo-means of HCC.
rovided a hair sample of sufﬁcient weight and an identiﬁable scalp
nd, completed a hair questionnaire and did not have missing data
n the covariates of interest. Mean age of participants at phase
1 was 70 years. The majority of participants were men  (68.4%),
eported their ethnicity as white (94.2%) and had a last known civil
ervice employment grade of executive or above. Sample collection
as distributed evenly across the year and most had been stored
or more than 18 months before analysis, because samples were
ssayed in a single run at the end of data collection. Seven percent
f participants (N = 264) were taking local corticosteroids and 2%
N = 70) systemic corticosteroids. The majority of the participants
rom whom samples were collected were free of chronic health
onditions and had a BMI  between 18.5 and 29.9. Table 2 shows
he characteristics of those included and not included in this anal-
sis. Overall the samples were similar across a range of variables,
lthough differences by sex and mean HCC were observed.
Table 3 shows that women had lower HCC than men  both before
nd after adjustment for potential confounders. There was no sig-
iﬁcant difference in HCC by age group or when age was used as
 continuous variable (percentage difference per year of age = 0.1%,
 = 0.73). There was no initial difference in HCC by ethnic group,
owever in mutually adjusted analysis those who  identiﬁed as
lack had nearly 40% higher HCC than White groups. In the ini-
ial simple linear regression analysis, HCC was lower in the lower
mployment grades (prof/exec clerical/support) than in the higher
administrative) employment grade, but this association attenu-
ted following adjustment.
Those who reported having dyed hair had lower HCC than those
ho did not. Although those who reported chemically treated hair
ad higher HCC initially, most of this difference was  removed after
djustment for demographic and other hair characteristics. There
as no signiﬁcant difference in HCC by frequency of hair wash-
ng in the linear model. However, after controlling for other hair
haracteristics those who washed their hair more than 4 times a
eek had lower HCC than those who only washed it once a week
r less, although this was not statistically signiﬁcant (p = 0.08). The
utually adjusted analysis showed that those with black hair had
lightly higher HCC on average, compared to those who had grey
r white hair.
Hair samples with hair growth from winter-spring, spring,
pring-summer, summer and summer-autumn had higher HCC
ompared to those collected in winter, but these differences85.9 0.011
remained for the winter-spring, spring, spring-summer and sum-
mer, seasons only in the adjusted analyses. HCC was lower in hair
samples stored for over 18 months, compared to those stored for
<18 months. A negative association (r = −0.02, p = 0.001) between
months of storage and HCC was  also observed when months of
storage was included as a continuous variable in unadjusted linear
analysis. The large difference observed between unadjusted and
adjusted analyses for months of storage is perhaps due to the cor-
relation between storage and season e.g. no sample collected in
Spring in the study was stored for <18 months.
Table 4 presents the association of HCC with medication intake
and health status. Participants who  took systemic corticosteroids
had lower HCC compared to those who did not and this asso-
ciation remained following adjustment for demographic factors,
hair characteristics and health status. Those who  were currently
taking CVD medication compared to those who were not, had
higher HCC initially, although this association was no longer sig-
niﬁcant in adjusted analysis. There was a signiﬁcant association
between BMI  and HCC, participants who  had a BMI  higher than
25 kg/m2 (healthy weight) had higher HCC. Participants with dia-
betes exhibited higher HCC than those who did not and this
remained signiﬁcant in the fully adjusted analysis. HCC was unre-
lated to CHD diagnosis or the experience of a stroke. A positive
association between HCC and depressive symptoms was observed
in the simple linear regression which remained when other factors
were taken into account (Fig. 1).
4. Discussion
This study is the ﬁrst to test the feasibility of using of hair cortisol
as a measure of long-term cortisol exposure in a large scale occu-
pational cohort study. Sample collection was well tolerated, quick
and relatively cheap. The study was well-powered to detect cor-
relates of HCC and our results show associations of HCC with hair
treatment, hair washing, season of sample collection and health
conditions.
We considered a group of hair speciﬁc factors, collected in the
accompanying questionnaire and which have been considered pre-
viously. Our results suggest those participants who  had black hair
having slightly higher HCC than those with grey/white hair. This
contrasts with previous research which suggests no inﬂuence of
natural hair colour on HCC in human hair samples (Dettenborn
152 J.G. Abell et al. / Psychoneuroendocrinology 73 (2016) 148–156
Table  3
Hair cortisol concentration by demographic and hair characteristics.
Characteristic Unadjusted Mutually adjusteda
Meanb % differencec (95% CI) P value % difference (95% CI) P value
Sex:
Male 3.80 Ref Ref
Female 2.90 −23.6 (−28.9, −17.8) <0.001 −17.0 (−24.8, −8.4) <0.001
Age  groups:
59–64 3.40 Ref Ref
65–74  3.55 4.4 (−3.9, 13.3.) 0.308 2.7 (−5.5, 11.6) 0.534
75–85  3.44 1.0 (−8.4, 11.4) 0.842 −2.2 (−11.9, 8.5) 0.670
Ethnicity:
White 3.48 Ref Ref
South  Asian 3.21 −7.9 (−22.4, 9.3) 0.344 −4.3 (−20.1, 14.6) 0.632
Black 4.44 27.3 (−9.9, 79.7) 0.171 39.6 (2.1, 99.0) 0.065
Other  4.24 21.6 (−17.7, 79.7) 0.326 32.7 (−10.2, 96.0) 0.156
Last  known grade:
Administrative 3.67 Ref Ref
Prof/exec 3.34 −9.0 (−15.3, −2.2) 0.010 −3.9 (−10.7, 3.5) 0.294
Clerical/support 3.19 −13.1 (−23.1, −1, −1.8) 0.025 1.1 (−11.6, 15.6) 0.871
Original hair colour:
Grey/White 3.48 Ref Ref
Blonde 3.01 −13.3 (−30.0,7.3) 0.189 −0.7 (−19.9, 23.1) 0.950
Red  3.45 −0.7 (−31.2, 43.1) 0.968 6.5 (−26.0, 53.2) 0.735
Brown 3.36 −3.3 (−12.7, 7.0) 0.514 4.3 (−6.1, 15.8) 0.434
Black  4.24 22.0 (4.9, 41.9) 0.010 23.7 (5.8, 44.7) 0.008
Hair  dyed:
No 3.65 Ref Ref
Yes  2.76 −24.3 (−30.9, −17.1) <0.001 −12.5 (−22.0, −1.9) 0.022
Hair  treated:
No 3.51 Ref Ref
Yes  2.99 −14.8 (−28.3, 1.2) 0.068 −0.6 (−17.0, 19.0) 0.945
Hair  washing:
≤Once a week 3.58 Ref Ref
2–4  times per week 3.42 −4.4 (−11.6, 3.5) 0.269 −3.8 (−11.3, 4.3) 0.343
≥5  times per week 3.50 −2.3 (−11.1, 7.3) 0.630 −8.4 (−17.0, 1.1) 0.081
Season collected:d
Winter 4.21 Ref Ref
Winter-spring 3.26 −22.7 (−32.1, −12.1) <0.001 −29.9 (−40.8, −17.0) <0.001
Spring 2.78 −34.0(−43.2, −23.3) <0.001 −36.0 (−46.7, −23.0) <0.001
Spring-summer 3.25 −23.0 (−32.0, −12.9) <0.001 −25.4 (−36.7, −12.2) <0.001
Summer 3.42 −18.8 (−29.9, −5.9) 0.006 −20.7 (−33.9, −4.8) 0.013
Summer-autumn 3.49 17.1 (−27.4, −5.4) 0.005 −12.9 (−24.4, 0.3) 0.056
Autumn 3.83 −9.2 (−21.7,5.3) 0.200 −6.4 (−20.2, 9.8) 0.420
Autumn-winter 3.86 −8.4 (−20.0, 4.8) 0.199 −7.4 (−20.1, 7.3) 0.306
Storage:
≤18  months 3.73 Ref Ref
19–24  months 3.77 1.1 (−8.5, 11.8) 0.825 −23.6 (−36.5, −8.1) 0.004
>24  months 3.14 −15.8 (−23.9, −6.9) 0.001 −18.0 (−26.1, −9.0) <0.001
a Adjusted for sex, age, ethnicity, grade, hair colour, hair dye, hair treatment, hair washing, season, storage.
b Unadjusted geometric means.
c Percentage difference in hair cortisol concentration from the reference group.
d An eight category variable was created to take account of hair growth which during t
Fig. 1. Geometric mean (±95% CI) Hair Cortisol Concentrations in participants by
CES-D depressive symptoms scale a.
aP value from t-test = 0.01.he three month sample overlapped two seasons.
et al., 2012a,b; Kirschbaum et al., 2009; Manenschijn et al., 2011;
Raul et al., 2004; Sauve et al., 2007). The majority of previous studies
have not distinguished between hair treatment and hair dye. Those
studies which did, found participants who had dyed their hair had
lower HCC, in accord with our results (Manenschijn et al., 2011;
Sauve et al., 2007). Studies which did not differentiate between
chemical treatment and hair dye also found lower HCC in partic-
ipants who  reported treating their hair (Manenschijn et al., 2012;
Stalder et al., 2013). In our study, we found that hair treatments,
such as perming or straightening, did not have an independent
association with HCC after adjusting for the presence of hair dye.
We see a consistent association between hair dye and HCC and
therefore recommend that information about whether participants
use hair dye is always collected and included in HCC analysis.
We found that participants who washed their hair every day
had lower HCC than those once a week or less, although this effect
was relatively small. This ﬁnding stands in contrast to most previ-
ous studies which have found no signiﬁcant relationship between
HCC and regular hair washing with shampoo (Groeneveld et al.,
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Table  4
Hair cortisol concentration by medication and health status.
Characteristic Unadjusted Fully adjusteda
Meanb % differencec (95% CI) P value % difference (95% CI) P value
Medications
Steriods:
No 3.50 Ref Ref
Yes  (local) 3.72 6.2 (−6.8, 21.2) 0.367 5.8 (−7.1,20.5) 0.393
Yes  (systemic) 2.17 −37.9 (−51.6, −20.4) <0.001 −37.5 (−51.0,−20.2) <0.001
CVD  drugs:
No 3.25 Ref Ref
Yes  3.66 12.5 (5.0, 20.6) 0.001 2.7 (−4.6, 10.5) 0.477
Health status
BMI:
Underweight 3.1 2.5 (−24.6, 39.4) 0.873 7.7 (−20.6,46.0) 0.634
Healthy weight 3.1 Ref Ref
Overweight 3.7 20.2 (11.4, 29.7) <0.001 17.7 (9.0, 27.0) <0.001
Obese 4.0 31.5 (19.7, 44.4) <0.001 33.0 (20.7, 46.5) <0.001
Diabetes:
No  3.4 Ref Ref
Yes  4.1 21.1 (9.9, 33.4) <0.001 14.7 (3.8, 26.8) 0.007
Coronary heart disease:
No 3.4 Ref Ref
Yes  3.6 6.8 (−1.0,15.2) 0.090 1.4 (−6.2, 9.5) 0.735
Stroke:
No  3.5 Ref Ref
Yes  3.9 12.5 (−6.9, 35.9) 0.222 6.0 (−12.1, 28.0) 0.541
Depressive symptoms:
No 3.44 Ref Ref
Yes  3.96 15.8 (4.3, 28.6) 0.008 20.0 (8.1, 33.3) 0.001
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b Unadjusted geometric means.
c Percentage difference in hair cortisol concentration from the reference group.
013; Kirschbaum et al., 2009; Manenschijn et al., 2011; Stalder
t al., 2013, 2010). An experimental study found HCC decreased
fter washing with shampoo (Li et al., 2012), although this was  only
ased on a sample size of three and hair samples were immersed
n a shampoo solution. Dettenborn et al. (2012a,b) found a nega-
ive association between hair washing frequency and HCC, but only
n the hair segment most distal from the scalp (Dettenborn et al.,
012a). Although an association between frequency of hair wash-
ng and HCC is suggested, this does not remain in mutually adjusted
nalysis. We  recommend that studies collect information about the
requency of hair washing and additional research explores this
ssue further.
Seasonal variation has been examined previously, with higher
CC reported in the summer months and lower HCC in winter
Braig et al., 2015; Staufenbiel et al., 2015). The present results
ased on a large sample and even sample collection across the
our seasons suggested seasonal differences in HCC in the opposite
irection, i.e. we found lower HCC in samples collected in winter-
pring, spring, spring-summer and summer seasons compared to
hose collected in the winter. This could suggest seasonal differ-
nces in environmental inﬂuences on hair samples or seasonal
ariation in long-term cortisol secretion. Several hypotheses for the
nﬂuence of season on HCC have been proposed, including temper-
ture, ﬂuid ingestion and transpiration (Braig et al., 2015). Seasonal
ariation in mood could also be a confounding factor, although, in
ur sample the association between HCC and season was  unaffected
hen adjustment was made for depressive symptoms. A possible
nteraction between season of sample collection and length of stor-
ge has also been suggested (Braig et al., 2015) although few studies
ave examined the inﬂuence of length of storage on HCC. We  found
 storage effect, with HCC lower in samples that had been stored for
onger. Importantly, our results suggest that the respective inﬂu-
nces of the season of hair collection and of sample storage are
ndependent of each other, i.e. they emerged after mutual account-
ng for each other. There are a number of reasons which mighting, season, storage steroid drugs, cvd drugs, diabetes, CHD and Stroke.
explain why previous ﬁndings on the seasonal variation in corti-
sol levels are inconsistent. Firstly the previous studies have used
samples drawn from different populations from different European
countries: Braig et al. (2015) examined the association between
season and HCC in a sample of mothers who had recently given birth
in Germany, whilst Staufenbiel and colleagues examined HCC in
healthy, middle-aged women and men  in the Netherlands (2015).
Although these are both European countries, it is possible that tem-
perature and humidity levels may  differ between these countries
and the UK. Furthermore, it is not possible to completely rule out
an interaction between season and storage in earlier studies. Since
in large scale observational studies it will not always be possible to
control the season which sample collection occurs in or the length
of sample storage, it is advisable to collect sufﬁcient information to
allow these environmental features to be taken into account.
Sex remained a signiﬁcant predictor of HCC in the present study
after adjustment for a range of other characteristics, with women
having lower HCC than men. Overall results from previous work on
sex differences in HCC have been mixed. A recent study found that
sex differences were not independent of other covariates (Feller
et al., 2014) and others have found no differences (Gao et al.,
2010; Manenschijn et al., 2011; Raul et al., 2004; Stalder et al.,
2013; Thomson et al., 2010). However, Dettenborn et al. (2012a,b)
also found elevated HCC in men  (Dettenborn et al., 2012b). This
accords with the present ﬁndings and also two  previous stud-
ies, which demonstrate higher HCC in males compared to females
(Manenschijn et al., 2013; Staufenbiel et al., 2015). A possible mech-
anism for higher HCC in men  compared to women is the higher 24-h
urinary glucocorticoid secretion rate in men  (Remer et al., 2008).
In common with the majority of previous studies (Kirschbaum
et al., 2009; Manenschijn et al., 2011, 2012; Raul et al., 2004; Stalder
et al., 2012a), we found no association between HCC and age in
our sample of participants aged 59–84. However, research that
has examined individuals across wider age ranges reported pos-
itive associations between age and HCC (Dettenborn et al., 2012b;
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eller et al., 2014; Stalder et al., 2013), with HCC increased for adults
etween 50 and 91 years. Although these differences may  be due to
he different samples under observation, this may  also suggest that
uch age-related changes in HCC occur in early old age. A recent
tudy which speciﬁcally examined HCC in adults between 47 and
2 years found age-related changes in HCC, which were consistent
ven after controlling for other factors (Feller et al., 2014). However,
trong positive correlations have also been observed between age
nd HCC in studies with narrower age ranges (Manenschijn et al.,
013; Staufenbiel et al., 2015).
Several hypotheses have been offered to explain a difference
n HCC by ethnicity (Wosu et al., 2015, 2013). Firstly, that certain
thnic groups are more likely to be exposed to social stressors, sec-
ndly that there are differences in the hair texture and growth rate
n different ethnic groups and thirdly that hair maintenance prac-
ices may  differ amongst ethnic groups. Our ﬁndings suggest higher
CC in Black groups compared to other ethnic groups. Studies from
he US have reported no differences by ethnicity and higher HCC in
lack groups (Wosu et al., 2015) (O’Brien et al., 2013), however both
ave suggested that their ﬁndings might be confounded by socioe-
onomic position. We  found that this association was independent
f last known employment grade, suggesting that socioeconomic
osition might not fully explain these disparities. We  also found
hese differences by ethnicity to be independent of washing fre-
uency, use of hair dye and chemical treatment which suggests that
air maintenance practices may  not account for these differences
ither. However, these ﬁndings require further analyses because
f the small number of cases of each different ethnic group in our
opulation.
In our study an initial difference in HCC by last known
mployment grade was found. However, this association was not
ndependent of sex. Several articles have examined the association
etween educational level and HCC in adults (Boesch et al., 2015;
erwinski et al., 2016) and children (Rippe et al., 2016). Chen et al.
2013) found no association between educational level and HCC in
dults in China. At the current screening many participants were
etired, therefore these analyses need further exploration with non-
ccupational measures of social position.
To the best of our knowledge, the association of medication
ntake with hair cortisol levels has not been examined, although
 study which examined general medication intake found no dif-
erence in HCC (Kirschbaum et al., 2009). Due to the size and
tructure of our cohort we were able to examine the association
etween HCC and several groups of medication. We  found that
hose who took systemic corticosteroids had lower HCC compared
o those who took no steroid medication. However, in a sample
hich retained outliers, both local and systemic were associated
ith higher mean HCC than those who did not (data not shown).
e  anticipate that certain outliers for the topical corticosteroids
ight be explained by participants using creams/gels that came
nto direct contact with the scalp/hair. Synthetic GCs (Dexametha-
one, Betamethasone, etc.) should not produce a cortisol-like signal
n the MS  (i.e. cross-react), only the use of actual hydrocortisone
edication would do this. In further analysis (Supplementary Table
1) we show that participants with lower hair cortisol were using
lucocorticoid therapy and those with higher hair cortisol were
sing topical corticosteroids. This suggests that perhaps some of
he extreme HCC results observed can be attributed to medication
se. Research which has examined HCC thus far tends to exclude
articipants taking corticosteroid medication from the study and
his seems to be a sensible strategy. We  also found evidence of
n association between BMI  and HCC, with participants with a
MI  25 kg/m2 or higher (overweight or obese) having higher mean
CC than their normal weight counterparts. This ﬁnding accords
ith previous research which ﬁnds an association of obesity with
reater cortisol excretion in urine, which also reﬂects overall outputrinology 73 (2016) 148–156
(Brunner et al., 2002) and studies that examine HCC and obe-
sity in children (Veldhorst et al., 2014) and adults (Feller et al.,
2014; Stalder et al., 2013, 2012a). Cortisol might be directly related
to adiposity in humans through adipocytes. Visceral adipose tis-
sue expresses high concentrations of glucocorticoid receptors (Pou
et al., 2007) and it is thought that adipocytes are a source of cortisol.
In humans increased 11-HSD1 activity, which regulates glucocor-
ticoid metabolism at the tissue level, has also been associated with
features of the metabolic syndrome (Walker and Andrew, 2006).
We also examined the association of HCC with three chronic
conditions; diabetes, CHD and stroke. The present results revealed
increased HCC in people with type 2 diabetes after full adjustment
for potential confounding inﬂuences. This concurs with previous
data of elevated HCC in patients with diabetes (Feller et al., 2014;
Henley et al., 2013; Manenschijn et al., 2013) and is also in line with
ﬁndings that HCC is positively related to glycated haemoglobin (a
marker of long-term plasma glucose concentrations) and preva-
lence of the metabolic syndrome (Stalder et al., 2013). Despite
previous research suggesting an independent relationship between
HCC and cardiovascular disease (Manenschijn et al., 2013) and ele-
vated HCC in patients with acute myocardial infarction (Pereg et al.,
2011) we  found no evidence of this in our cohort. Although we
ﬁnd an association between taking CVD medication and HCC, this
does not remain when other factors, such as BMI, were taken into
account. Certain CVD medications, e.g. statins, are prescribed in
high-risk disease-free groups for primary prevention in addition
to being prescribed as therapy for CHD patients. Certain CVD risk
factors are considered by family doctors (GPs) in the UK as predic-
tive of developing CVD at some point in the next ten years. HCC may
be associated with these risk factors and predictive of being pre-
scribed CVD medication rather than being actual markers of CHD
or stroke. We  have provided further information (Supplementary
Table S2) in Appendix A to demonstrate this. Furthermore, it is pos-
sible that. statin use is causing weight gain (Swerdlow et al., 2015)
which is then associated with HCC (p. 6).
We  found an independent association between depressive
symptoms, measured using the CES-D scale and HCC, such that
those who  reported more depressive symptoms had increased
HCC. This accords with previous ﬁndings (Dettenborn et al., 2012a;
Stalder et al., 2014), although most work in this area has been on
small samples recruited because of their diagnosis or an existing
physical health condition (Staufenbiel et al., 2013). Therefore, we
believe this to be the ﬁrst report of an independent association
between depressive symptoms and HCC in a large observational
cohort.
There are certain limitations that must be acknowledged. At this
phase (11) of the study, only hair cortisol data were available, thus
the HCC results presented here could not be compared to those
from other types of body ﬂuids. Since this ﬁeld of research is in
its infancy, a clear distribution of potential values has not been
established, although this is perhaps comparable to other existing
methods of cortisol assessment, e.g. in saliva or urine. Due to the
age and demographic distribution of this cohort, a number of par-
ticipants were not able to provide a hair sample of sufﬁcient length
for analysis. Although we  attempted to minimise within individual
variation in hair growth by taking hair from the vertex posterior
region of the head, hair growth rates may  vary between individu-
als. Furthermore the participants in this cohort at this phase have a
mean age of 70 years older, therefore it may  not possible to gener-
alise the ﬁndings of this study to younger adults. In the Whitehall II
cohort there are few participants who report that they are from an
ethnic group other than white, therefore our ﬁnding on the asso-
ciation between ethnicity and HCC is not generalizable to a wider
population and additional research will be required to explore this
further. There are, however, strengths to this study, primarily that
hair samples have been drawn from a large sample, from which a
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ange of other variables have also been assessed. In addition, the
uantiﬁcation of HCC by LC–MS/MS, which is considered the cur-
ent gold-standard approach for such analyses, comprises a clear
trength of this paper.
Collecting hair samples in occupational cohorts present sig-
iﬁcant opportunities for assessing cortisol and other steroids;
specially since the collection is cheaper and less invasive than
revious methods of measuring cortisol. We  conclude that sev-
ral demographic factors, hair characteristics and details of hair
are routines are correlated with hair cortisol and are important to
ollect when wishing to analyse cortisol in hair. We  recommend
hat information on medication and seasonal variation should be
ollected and considered as possible confounders in analyses. We
lso recommend that further research assesses the impact of stor-
ge length on hair samples and that information regarding storage
ength be recorded and taken into account in the analysis. Simi-
arly, mental and physical health is associated with HCC levels and
hould be taken into in the analysis. We  therefore recommend col-
ecting hair samples for assessing HCC if long-term levels of cortisol
re of interest and a high response rate is unlikely using traditional
epeated urine or saliva measures.
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